Cannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International Limited

Cannara Biotech has secured a long-term international supply agreement with Curaleaf International valued at up to C$21 million, marking a significant commercial milestone for the vertically integrated cannabis producer. This agreement represents contracted revenue visibility and validates Cannara's production scale at its two Quebec mega-facilities totaling 1.6 million square feet.

The transaction underscores consolidation dynamics within the cannabis sector, where larger producers with established cultivation capacity seek supply partnerships to serve international markets. The committed volume structure suggests revenue stability rather than speculative growth, reducing execution risk relative to purely exploratory expansion initiatives.

For LOVFF, this agreement provides tangible revenue diversification beyond domestic Canadian markets into international channels, a key growth lever for cannabis producers navigating mature North American regulatory environments. CURLF gains secured supply of bulk flower for downstream international distribution, improving unit economics and sourcing reliability.

Sector implication: The deal signals operational maturation in cannabis supply chains and international market development, though sentiment remains muted due to cannabis sector volatility and regulatory uncertainty across geographies. This is a positive but incremental catalyst within a fundamentally challenged industry sector.